Clinical Trial Update: Study of L-NDDP (Aroplatin) in Patients With Advanced Solid Malignancies or B-Cell Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 study of L-NDDP (Aroplatin) in patients with advanced solid malignancies or B-cell lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Solid Tumors

Drugs mentioned

• L-NDDP (Aroplatin) (L-NDDP)

Snippet

Sponsor: Agenus Inc. | Conditions: Malignancies, B-Cell Lymphoma | Phase 1 | Status: COMPLETED